NASDAQ: TLSITrisalus Life Sciences Inc Stock
$5.50-0.09 (-1.61%)
Updated Sep 22, 2023
TLSI Price
$5.50
Fair Value Price
N/A
Market Cap
$40.67M
52 Week Low
$4.57
52 Week High
$16.24
P/E
-36.67x
P/B
-2.69x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$1.13M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$3M
Beta
0.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TLSI Overview
MedTech Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare sector in the U.S. MedTech Acquisition was incorporated in 2020 and is headquartered in Greenwich, CT.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TLSI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TLSI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TLSI is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
TLSI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more TLSI due diligence checks available for Premium users.
Be the first to know about important TLSI news, forecast changes, insider trades & much more!
TLSI News
Valuation
TLSI fair value
Fair Value of TLSI stock based on Discounted Cash Flow (DCF)
Price
$5.50
Fair Value
$10.71
Undervalued by
48.62%
TLSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TLSI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-36.67x
Industry
49.22x
Market
14.52x
TLSI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-2.69x
Industry
3.54x
TLSI's financial health
Profit margin
Revenue
$0.0
Net Income
-$995.0k
Profit Margin
0%
TLSI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$12.2M
Liabilities
$15.3M
Debt to equity
-1.01
TLSI's short-term liabilities ($6.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TLSI's long-term liabilities ($9.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TLSI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TLSI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$313.9k
Investing
$8.4M
Financing
-$8.1M
TLSI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TLSI vs Medical Device Stocks
Trisalus Life Sciences Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.